Best Medicare Plans for Depression & Anxiety Medications (2026 Guide)
About 25% of Medicare beneficiaries take at least one psychiatric medication — and for most of them, the drugs they need are among the cheapest in the entire Medicare formulary. Generic SSRIs and SNRIs like sertraline, escitalopram, and duloxetine cost $0–$10 per month on virtually every plan. What varies — and what can cost you significantly more — are brand-name antidepressants, atypical antipsychotics, mood stabilizers, and plans with heavy prior authorization requirements on psychiatric medications.
Why Medicare Coverage Varies for Psychiatric Medications
Every Medicare Advantage plan and standalone Part D plan sets its own formulary — a tiered drug list where each tier carries a different copay or coinsurance. There is no single national Medicare formulary. A plan in Phoenix and a plan in Philadelphia covering the same beneficiary can place identical medications on Tier 1 ($0–$5) or Tier 3–4 ($40–$150+).
For mental health medications specifically, three factors drive most of the variation:
- Generic vs. brand-name status. The most commonly prescribed antidepressants — sertraline (Zoloft), escitalopram (Lexapro), duloxetine (Cymbalta), bupropion (Wellbutrin), fluoxetine (Prozac) — all have well-established, cheap generics. Plans typically place them at Tier 1 or Tier 2. Brand-name versions, where generics exist, land at Tier 3–5 and cost dramatically more.
- Prior authorization and step therapy. Some plans require you to try and fail cheaper alternatives before they'll cover a more expensive medication — even if your psychiatrist prescribed the brand-name for a specific clinical reason. These restrictions are more common for brand-name antidepressants, atypical antipsychotics, and newer medications without generic equivalents.
- Atypical antipsychotics and mood stabilizers. If you take medications for bipolar disorder, schizophrenia, or as adjunct therapy for treatment-resistant depression — such as aripiprazole (Abilify), quetiapine (Seroquel), or lamotrigine — formulary placement and prior auth requirements can vary much more significantly than they do for simple SSRIs.
The most-prescribed antidepressants in Medicare all have cheap generics that have been on the market for years. If your prescriber writes for generic sertraline, escitalopram, duloxetine, or bupropion, your monthly cost on almost any Medicare plan is $0–$10. The plan comparison still matters — for deductibles, Part B mental health visit coverage, and any non-generic medications you may need — but basic antidepressant formulary variation is modest. Where variation gets significant: brand-only drugs, atypical antipsychotics, and plans with aggressive step therapy policies.
Drug Classes and Formulary Tier Differences
There are several classes of medications commonly prescribed for depression, anxiety, and related conditions. Here's how each class behaves across Medicare formularies and what to watch for.
SSRIs (Selective Serotonin Reuptake Inhibitors)
SSRIs are the first-line treatment for depression and most anxiety disorders. All major SSRIs are available as generics: sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), paroxetine (Paxil), citalopram (Celexa), and fluvoxamine. Plans universally place these at Tier 1 with $0–$5 copays. If you're only on a generic SSRI, your formulary comparison is simple: virtually every plan covers it cheaply.
The exception: if your prescriber specifically writes for brand-name Lexapro, Zoloft, or Prozac rather than the generic equivalent, those brand-name versions land at Tier 3–4. Confirm with your prescriber whether generic substitution is clinically acceptable — for most patients, it is, at a fraction of the cost.
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
SNRIs are commonly used for depression, generalized anxiety disorder, and certain pain conditions. Generic duloxetine (Cymbalta), venlafaxine (Effexor XR), and desvenlafaxine (Pristiq) are all available. Generic duloxetine and venlafaxine are typically Tier 1–2 across most plans. However, Pristiq (desvenlafaxine brand) and extended-release brand formulations of older SNRIs can still land at Tier 3–4 on some plans when the generic is available.
Venlafaxine XR (extended-release) deserves special attention: the immediate-release generic is usually cheaper than the ER version. If your plan places venlafaxine XR at a higher tier, ask your prescriber whether immediate-release twice-daily dosing is an acceptable alternative — same molecule, lower cost.
Bupropion (Wellbutrin / Zyban)
Bupropion is an atypical antidepressant frequently used for depression and smoking cessation. Generic bupropion and bupropion XL are both widely available and typically placed at Tier 1–2. Brand-name Wellbutrin XL and SR are Tier 3–4 where generics exist. Bupropion is also one of the few antidepressants with coverage nuance: it's sometimes covered under Part B's smoking cessation benefit in addition to Part D drug coverage, depending on how it's prescribed.
Buspirone (BuSpar)
Buspirone is commonly prescribed for generalized anxiety disorder as a non-addictive alternative to benzodiazepines. Generic buspirone is inexpensive and almost always at Tier 1 across Medicare plans. If you're on buspirone for anxiety, your formulary cost is minimal on any plan.
Benzodiazepines
Benzodiazepines — alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), diazepam (Valium) — are a special case in Medicare. While the generics are extremely inexpensive and typically Tier 1–2, Medicare Part D plans may impose additional restrictions on benzodiazepine coverage due to their controlled substance status and CMS guidelines around appropriate use in elderly patients. Some plans require prior authorization for benzodiazepines, and certain plans limit quantities dispensed per fill. Verify your plan's specific rules for benzodiazepines before enrolling.
Atypical Antipsychotics (Adjunct and Primary Use)
Atypical antipsychotics are used both as primary treatment for schizophrenia and bipolar disorder, and as adjunct therapy when antidepressants alone are insufficient for depression. This class is where formulary variation matters most for mental health patients:
- Aripiprazole (Abilify) — generic available; typically Tier 2–3. Brand Abilify is Tier 4–5 on most plans.
- Quetiapine (Seroquel) — generic available; typically Tier 2. Brand Seroquel XR is Tier 3–4.
- Olanzapine (Zyprexa) — generic available; typically Tier 2. Brand is much higher.
- Lurasidone (Latuda), Brexpiprazole (Rexulti), Cariprazine (Vraylar) — these newer atypical antipsychotics have limited or no generic availability and are typically Tier 4–5 specialty drugs. Monthly costs can be $100–$400+ depending on the plan and whether prior authorization is required.
If you're prescribed a newer atypical antipsychotic without a generic, formulary comparison across plans is critical. The same drug can cost $50/month on one plan and $350/month on another with different tier placement or coinsurance percentages.
Mood Stabilizers
Lithium, valproic acid (Depakote), and lamotrigine (Lamictal) are the primary mood stabilizers used in Medicare. All three have generic versions and are typically Tier 1–2 across most plans. Brand-name Depakote ER and Lamictal are higher-tier, but generics work clinically for most patients. The exception: lamotrigine has a narrow therapeutic index, and some prescribers specifically request the brand — verify your plan covers it before enrolling.
| Drug | Class | Typical Tier | Est. Monthly Copay | Notes |
|---|---|---|---|---|
| Sertraline (generic / Zoloft) | SSRI | Tier 1 | $0–$5 | Universal Tier 1; brand Zoloft is Tier 3–4 |
| Escitalopram (generic / Lexapro) | SSRI | Tier 1 | $0–$5 | Universal Tier 1; brand Lexapro is Tier 3–4 |
| Duloxetine (generic / Cymbalta) | SNRI | Tier 1–2 | $0–$15 | Generic widely available; brand Cymbalta is Tier 3–4 |
| Bupropion XL (generic / Wellbutrin) | Atypical antidepressant | Tier 1–2 | $0–$15 | Generic available; brand Wellbutrin XL is Tier 3–4 |
| Buspirone (generic / BuSpar) | Anxiolytic | Tier 1 | $0–$5 | Inexpensive generic; universal Tier 1 |
| Alprazolam (generic / Xanax) | Benzodiazepine | Tier 1–2 | $0–$15 | May require prior auth; quantity limits common |
| Quetiapine (generic / Seroquel) | Atypical antipsychotic | Tier 2 | $10–$30 | Generic available; brand Seroquel XR is Tier 3–4 |
| Aripiprazole (generic / Abilify) | Atypical antipsychotic | Tier 2–3 | $15–$50 | Generic available; brand Abilify is Tier 4–5 |
| Lamotrigine (generic / Lamictal) | Mood stabilizer | Tier 1–2 | $0–$20 | Generic preferred; verify if brand-only prescribed |
| Lurasidone (Latuda) / Brexpiprazole (Rexulti) | Atypical antipsychotic (brand-only) | Tier 4–5 | $100–$400+ | No generic; prior auth common; plan varies widely |
Tier placements and copays vary by plan and change annually. Always verify your specific plan's formulary before enrolling.
Step Therapy and Prior Authorization for Psychiatric Medications
Step therapy — sometimes called "fail first" — is a policy where an insurance plan requires you to try a cheaper medication before it will cover the one your prescriber originally ordered. It's common across all drug classes, but for psychiatric medications, it raises particular concerns because mental health medication management is highly individualized.
In practice, step therapy for mental health medications can mean:
- Your plan requires you to try generic sertraline before it covers brand-name Lexapro (this is usually clinically reasonable)
- Your plan requires you to fail two generic antidepressants before covering an atypical antipsychotic adjunct like Rexulti (this can delay appropriate treatment)
- Your plan requires prior authorization documentation from your prescriber before covering a newer antidepressant — creating administrative burden and potential treatment delays
Medicare plans must have a process for formulary exceptions — and for psychiatric medications, your prescriber can often obtain an exception when there's a documented clinical reason the required step-therapy drug is inappropriate. Examples: prior medication trial that failed, documented adverse effect, psychiatric contraindication. If your plan denies coverage for a medication your prescriber recommends, ask your doctor to file a formal exception request. Plans are required to respond to standard exception requests within 72 hours (24 hours for urgent requests). You also have the right to an Independent Review Entity (IRE) appeal if the plan denies the exception.
When comparing plans, look specifically at the prior authorization requirements for the medications you take — not just the tier placement. A plan that places your medication at Tier 2 with prior auth required may be more burdensome than a plan with Tier 3 and no prior auth, depending on how easily your prescriber can get the authorization approved.
Medicare Part B Coverage for Mental Health Services
Medicare's mental health coverage extends beyond just Part D drug coverage. Part B covers several mental health services that are relevant if you see a therapist, psychologist, or psychiatrist as part of your treatment.
Outpatient Mental Health Visits
Medicare Part B covers outpatient mental health services, including visits with psychiatrists, psychologists, clinical social workers, and licensed counselors. Under Original Medicare, you pay 20% of the Medicare-approved amount after meeting your Part B deductible. Medicare Advantage plans must cover these services at least as generously as Original Medicare, but specific copays and network requirements vary by plan.
Key distinction: visits with a psychiatrist for medication management (a medical service) are billed differently than psychotherapy sessions (a mental health service) — though both are Part B covered. If you see a psychiatrist who also provides talk therapy in the same visit, the billing may split between evaluation and management versus psychotherapy components.
Annual Depression Screening — Free Under Medicare
This is one of the most underutilized free benefits in Medicare: annual depression screening is covered at no cost to you under the Medicare Annual Wellness Visit and as a standalone preventive service. No deductible, no copay. Your primary care physician can perform the screening using a validated tool (PHQ-2, PHQ-9) as part of your annual wellness visit or a separate preventive visit.
If the screening is positive, Medicare covers referral and follow-up services. Many Medicare beneficiaries with undiagnosed or undertreated depression are unaware this screening is available to them annually at zero cost.
Telehealth Mental Health Services
Post-2020, Medicare significantly expanded telehealth coverage for mental health services. Beneficiaries can now receive outpatient mental health services via telehealth from their home without geographic restrictions that previously limited rural access. Medicare Advantage plans vary in how they implement telehealth for mental health — some have lower copays for telehealth visits than in-person, and some offer expanded mental health telehealth networks that go beyond Original Medicare's baseline. If telehealth is important to your mental health care, compare plans specifically on their telehealth mental health benefits.
Medicare Advantage plans are required to comply with mental health parity rules, meaning they cannot impose more restrictive cost-sharing, prior authorization, or visit limits on mental health services than they do on comparable medical/surgical services. In practice, compliance varies and parity complaints are not uncommon. If you believe a plan is applying more restrictive rules to your mental health care than to equivalent physical health care, you have the right to file a complaint with CMS or your State Insurance Commissioner.
When Plan Choice Matters Most for Mental Health Patients
For most Medicare beneficiaries on generic antidepressants alone, drug formulary differences are minimal — the drugs are too cheap across the board for plan choice to be driven primarily by formulary. Where plan selection matters significantly:
You're on a brand-name or specialty psychiatric medication
If you take Latuda, Rexulti, Vraylar, Trintellix, Fetzima, or any other brand-name psychiatric medication without a generic equivalent, the formulary differences across plans can be $100–$400 per month. These drugs are Tier 4–5 specialty medications, and plan-specific coinsurance rates (20% vs. 33% vs. 50%) create enormous out-of-pocket variation.
Your plan's prior authorization rules create treatment barriers
Some plans have aggressive step therapy policies for psychiatric medications, requiring documentation of multiple prior medication failures before covering the medication your prescriber recommends. If you've already found a regimen that works — especially after years of trying different medications — a plan that would require you to restart step therapy creates both clinical risk and administrative burden.
You see a psychiatrist or therapist regularly
If mental health visits are part of your regular care, plan network and visit cost-sharing matter considerably. HMO plans require in-network providers — if your psychiatrist is not in the plan's network, you'd need to switch providers or pay full out-of-pocket rates. PPO plans allow out-of-network access but at higher cost-sharing. Verify your specific mental health providers are in-network before enrolling in any plan.
Mental health care co-occurs with other conditions
Depression and anxiety frequently co-occur with cardiovascular disease, diabetes, and chronic pain. If you manage multiple conditions and take medications for several of them, the formulary comparison for your complete medication list — not just the psychiatric drugs — drives your total annual drug cost. A plan that covers your antidepressant cheaply but places your heart disease medication at a high tier may still cost you more overall.
5-Step Framework for Comparing Medicare Plans for Mental Health Medications
Choosing a plan based on premium is the most common mistake. For mental health patients especially, drug formulary and provider network are often more important than the monthly premium. Here's the right framework:
Step 1: List every medication you take — not just psychiatric drugs
Include dosage, frequency, and whether you currently take a generic or brand-name version. Mental health medications rarely exist in isolation — most beneficiaries take medications for multiple conditions. The formulary comparison only works if it covers your complete medication list.
Step 2: Check prior authorization requirements for each psychiatric medication
Before looking at tier and copay, verify whether your plan requires prior authorization for each psychiatric medication you take. If prior auth is required, understand what documentation your prescriber will need to provide and whether your current medication history satisfies any step therapy requirements. A low-tier drug with burdensome PA requirements may not be as favorable as a slightly higher-tier drug with no restrictions.
Step 3: Verify your psychiatrist, psychologist, and therapist are in-network
Mental health provider networks are often narrower than general medical networks. The mental health provider shortage means in-network availability can vary significantly by plan in the same zip code. Don't rely solely on the plan's online directory — directories can be out of date. Call the plan's provider relations line to confirm your specific providers are accepting new patients in-network under the plan you're considering.
Step 4: Estimate total annual cost including Part B cost-sharing
If you have regular mental health visits, estimate the cost of those visits under each plan option — not just drug costs. A plan with low drug copays but $50/visit mental health copays may cost more annually than a plan with slightly higher drug costs and $20/visit copays, depending on how frequently you see providers.
Step 5: Check the annual out-of-pocket maximum (MOOP)
For Medicare beneficiaries managing complex mental health conditions with specialty medications and frequent provider visits, the out-of-pocket maximum can matter significantly. In 2026, CMS caps Medicare Advantage in-network MOOP at $9,350 — but many plans set lower limits. Plans with lower MOOPs provide better catastrophic protection if your total spending is high.
This is your main window to change Medicare plans, with coverage starting January 1. If your current plan changed its formulary for your psychiatric medications, added new prior authorization requirements, or dropped a mental health provider from the network, this is your window to switch. Review your plan's Annual Notice of Change letter (mailed each September) before it takes effect in January. Mental health medication formulary changes are common from year to year — don't assume your current coverage continues unchanged.
15 questions to ask before choosing a plan — medications, doctors, costs, and extra benefits. Print-friendly.
Find the Best Medicare Plan for Your Mental Health Medications
Enter your zip code, add your antidepressants or psychiatric medications, and PlanPilot scores every plan in your area on drug coverage, provider network, annual cost, and quality. Takes under 60 seconds. No account required.
Get your personalized plan match